InvestorsHub Logo
Followers 20
Posts 1945
Boards Moderated 0
Alias Born 08/29/2018

Re: None

Tuesday, 01/03/2023 9:41:09 AM

Tuesday, January 03, 2023 9:41:09 AM

Post# of 694317
In 2014 UK designated DCVax-L as first drug to be considered for early access approval under recently enacted EAMS program at that time .

It would make sense the real world information they had gathered would surpass any info available to any other RA in the world and thereby allowing a faster assessment for approval now.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News